A B S T R A C T The effect of 8-L-arginine vasopressin (AVP) on biosynthesis of prostaglandins in human mononuclear phagocytes was examined. AVP, oxytocin, and deamino-(8-D-arginine) vasopressin (dDAVP) affected prostaglandin biosynthesis in a rank order that parallels their pressor but not antidiuretic activity (AVP > oxytocin > dDAVP). Radioimmunoassay, incorporation studies using ['4C]arachidonic acid and radiometric thin-layer chromatography, revealed prostaglandin E2 (PGE2) to be the only prostaglandin synthesized by the mononuclear phagocytes.
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While high concentrations of PGE2 elevated cytoplasmic levels of cyclic AMP by five-to sevenfold above basal values, low concentrations of PGE2 that are released by the cells in the presence of AVP failed to increase cyclic AMP content in the cells. However, PGE2 at concentrations that do not alter cyclic AMP levels markedly interferes with the activity of AVP. This effect is, however, very time dependent. Addition of PGE2 to the cells 30 min before AVP, was followed by a period of unresponsiveness to the hormone that lasts at least 30 min. Pretreatment of the cells with indomethacin enhanced the AVP-mediated accumulation of intracellular cyclic AMP level. PGE2 did not modify [3H]AVP binding, indicating that its inhibitory effect on the activity of the peptide is not due to downregulation of vasopressin receptors. INTRODUCTION We have recently characterized specific 8-L-arginine vasopressin (AVP)' receptors on the circulating mononuclear phagocytes of human blood by using direct Received for publication 10 (1) . An important observation in these studies was that AVP affects cyclic AMP metabolism of these cells at comparable concentrations that are effective in mediating the activity of AVP on osmotic water flow in toad bladder as well as in mammalian collecting duct.
It is well established that the increase in permeability to water that AVP elicits in both the renal collecting duct and the toad urinary bladder involves stimulation of the formation of cyclic AMP (2) . Low concentrations of prostaglandin (PG) E2 have been shown to antagonize the antidiuretic activity of AVP by inhibiting the accumulation of cyclic AMP in epithelial cells of the toad bladder (3) and in slices of renal medulla (4) . In addition to its stimulatory effect on intracellular cyclic AMP level, AVP was also shown to increase biosynthesis of PGE2 in cultured interstitial cells from renal medulla of rabbit (5) . Thus, a shortloop feedback system has been proposed in which AVP itself stimulates its antagonist PGE2 in collecting duct epithelial cells (6) (7) (8) .
To evaluate whether human mononuclear phagocytes display certain characteristics of AVP action described for the renal tissue, we determined the effect of the hormone on PGE2 biosynthesis. Further, we studied the interactions between AVP and PGE2 on cyclic AMP metabolism of these cells. (Fig. 1) . Thus, the efficacy of AVP and its analogs to stimulate biosynthesis of PGE2 corresponds to the rank order of pressor activity of the polypeptides (AVP > oxytocin > dDAVP; (14, 15 Fig. 3 , there was only one radioactive peak that comigrated with authentic PGE2. Similarly, when using cells which had [3H]AA incorporated into cellular lipids, AVP increased the release of radioactive PGE2 and AA but not that of any other product of fatty acid cyclooxygenase (Fig. 4) .
METHODS
The effect of PGE2 on cyclic AMP metabolism of human mononuclear phagocytes. Prostaglandins have been shown to be formed within AVP-sensitive tissues (16, 17) . To study whether PGE2 affects cyclic AMP metabolism of mononuclear phagocytes, varying amounts of PGE2 were added to the cells and accumulation of intracellular cyclic AMP was determined. As shown in Fig. 5 , high concentrations of PGE2 (10-4 M) increased intracellular cyclic AMP level by approximately five-to sevenfold above those that were achieved in the presence of AVP (500 pM) and approximately threefold above those that were caused by the 03-adrenergic agonist dl-isoproterenol (10-4 M).
However, when using low concentrations of PGE2 that are released by cells after incubations with AVP (at concentrations that are effective in vivo), intracellular of AVP in highly purified T and B lymphocytes (purity by 95%), thrombocytes (purity by 90%), polymorphonuclear leukocytes (purity by 96%), erythrocytes (purity by 97%), and basophils isolated from a patient with chronic myelogenous leukemia (purity by 65%) (data not shown).
Antagonism between PGE2 and AVP on intracellular cyclic AMP level of human mononuclear phagocytes. Low concentrations of PGE2 have been reported to inhibit AVP-induced cyclic AMP metabolism in various tissues (18) . To evaluate whether PGE2 antagonizes the AVP-dependent raise in intracellular cyclic AMP in human mononuclear phagocytes, the cells were preincubated for various time intervals with PGE2 (10-M) before the addition of AVP (500 pM) for an additional 30 min. If 30 min were permitted to elapse before the addition of AVP, the inhibitory effect of PGE2 on accumulation of intracellular cyclic AMP due to AVP was most pronounced (Table II) . The greatly reduced response to AVP by a pulse of PGE2 could almost be diminished by extensive washing of the cells (three times for 10 min). Little, if any, interference with the activity of AVP on cyclic AMP metabolism of mononuclear phagocytes was seen when the peptide was added either simultaneously or before the addition of PGE2.
To study the effect of indomethacin on AVP-mediated cyclic AMP accumulation in mononuclear phagocytes, the cells were incubated for 30 min in the presence and absence of indomethacin before addition of AVP. As shown in Fig. 6 Basal level with IBMX (10' 
DISCUSSION
AVP and its analogues have been reported to increase PGE2 biosynthesis in various tissues (7, 19) . The stimulation of renal biosynthesis of PGE2 by AVP in mammalian kidney, however, is difficult to evaluate, for only urinary PGE have been determined. Urinary PGE include a portion of circulating PGE that were filtered or secreted into tubules as well as PGE that were synthesized within the kidney (20) .
Although one cannot formally exclude the possibility that small numbers of cells could be responsible for the reported effects of our studies, we conclude that mononuclear phagocytes contribute to the release of PGE2 into circulation. This is evidenced from the observation that highly purified T and B lymphocytes, polymorphonuclear leucocytes, erythrocytes, thrombocytes, and basophils lacked significant response to AVP. In addition, highly purified mononuclear phagocytes from human circulating blood and mouse peritoneal macrophages have been shown to be capable of releasing PGE2 in the presence of potent stimulators, e.g., endotoxic lipopolysaccharide (21) . The effectiveness in the stimulation of PGE2 biosynthesis of approximately twofold over basal values in response AVP (500 pM) and its analogues oxytocin (-.1/4-fold) and dDAVP (-0.5-fold) is comparable with that obtained from studies with rat medullary interstitial cells (5 Beck et al. (4) , who demonstrated a reduced response in the accumulation of cyclic AMP to AVP in epithelial cells of the bladder and in slices of renal medulla by low concentrations of PGE2. The time at which PGE2 is added in relation to AVP thereby appears to be critical. For example, those concentrations of PGE2 that cause no significant elevation in cytoplasmic cyclic AMP levels must be added before AVP. If, however, PGE2 is added either simultaneously or after AVP, it no longer has an effect on the ability of AVP to stimulate cyclic AMP metabolism of monocytes. This indicates that those steps in the activity of AVP that are sensitive to effects of cyclic AMP, are the earliest steps involved in the sequence, whereas there are later steps or components involved in the action of AVP that are no longer sensitive to the effect of cyclic AMP. The finding that indomethacin treatment enhanced the AVP-mediated raise in cyto- 
